Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

Similar articles for PubMed (Select 12803676)

1.

Approved and future pharmacotherapy for multiple sclerosis.

Stüve O, Cree BC, von Büdingen HC, Yousef S, Bowen JD, Genain CP, Hauser SL, Steinman L, Zamvil SS.

Neurologist. 2002 Sep;8(5):290-301.

PMID:
12803676
2.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
3.

Putative mechanisms of action of statins in multiple sclerosis--comparison to interferon-beta and glatiramer acetate.

Neuhaus O, Stüve O, Archelos JJ, Hartung HP.

J Neurol Sci. 2005 Jun 15;233(1-2):173-7. Epub 2005 Apr 20. Review.

PMID:
15949504
4.

Current approved options for treating patients with multiple sclerosis.

Rizvi SA, Agius MA.

Neurology. 2004 Dec 28;63(12 Suppl 6):S8-14. Review.

PMID:
15623672
5.

[Immunomodulatory therapy in multiple sclerosis].

Csépány T, Bereczki D.

Ideggyogy Sz. 2004 Nov 20;57(11-12):401-16. Review. Hungarian.

PMID:
15662768
6.

Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis.

Moses H Jr, Brandes DW.

Curr Med Res Opin. 2008 Sep;24(9):2679-90. doi: 10.1185/03007990802329959 . Epub 2008 Aug 8.

PMID:
18694542
7.

Glatiramer acetate for the treatment of multiple sclerosis.

Wolinsky JS.

Expert Opin Pharmacother. 2004 Apr;5(4):875-91. Review.

PMID:
15102570
8.

[Mitoxantrone for the treatment of patients with multiple sclerosis].

Komori M, Kondo T, Tanaka M.

Brain Nerve. 2009 May;61(5):575-80. Review. Japanese.

PMID:
19514518
9.

Evaluation of mitoxantrone for the treatment of multiple sclerosis.

Jain KK.

Expert Opin Investig Drugs. 2000 May;9(5):1139-49. Review.

PMID:
11060734
10.

Differentiation of multiple sclerosis subtypes: implications for treatment.

Bitsch A, Brück W.

CNS Drugs. 2002;16(6):405-18. Review.

PMID:
12027786
11.

Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis.

Dudesek A, Zettl UK.

J Neurol. 2006 Sep;253 Suppl 5:V50-8. Review. Erratum in: J Neurol. 2008 Feb;255(2):308.

PMID:
16998754
12.

Statins and their potential targets in multiple sclerosis therapy.

Stüve O, Prod'homme T, Slavin A, Youssef S, Dunn S, Steinman L, Zamvil SS.

Expert Opin Ther Targets. 2003 Oct;7(5):613-22. Review.

PMID:
14498824
13.

[Escalating immunomodulatory therapy of multiple sclerosis. Update (September 2006)].

Multiple Sklerose Therapie Konsensus Gruppe (MSTKG), Rieckmann P.

Nervenarzt. 2006 Dec;77(12):1506-18. German.

PMID:
17136556
14.

Management of worsening multiple sclerosis with mitoxantrone: a review.

Fox EJ.

Clin Ther. 2006 Apr;28(4):461-74. Review.

PMID:
16750460
16.
17.

[Drug therapy in multiple sclerosis].

Le Page E, Edan G.

Rev Prat. 2006 Jun 30;56(12):1336-46. Review. French.

PMID:
16948222
18.

Mitoxantrone in the treatment of multiple sclerosis.

Morrissey SP, Le Page E, Edan G.

Int MS J. 2005 Nov;12(3):74-87. Review.

PMID:
16417821
19.

Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.

Stuart WH.

Curr Med Res Opin. 2007 Jun;23(6):1199-208. Epub 2007 Apr 23. Review.

PMID:
17559719
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk